Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|March 10, 2023
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancerSameh Daher, Alona Zer, Roi Tschernichovsky, et al.
Journal of Clinical Medicine|May 14, 2022
<i>FGFR</i> Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)Ari Raphael, Elizabeth Dudnik, Dov Hershkovitz, et al.
The Oncologist|March 19, 2022
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world DataMor Moskovitz, Elizabeth Dudnik, Sivan Shamai, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Molecular Cancer Therapeutics|December 14, 2002
Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxinDominic Fan, Seiji Yano, Hisashi Shinohara, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
Frontiers in Oncology|June 1, 2022
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2<sup>nd</sup>/3<sup>rd</sup>-Generation ALK Tyrosine Kinase Inhibitors (TKIs)Ari Raphael, Amir Onn, Liran Holtzman, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2017
Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality StrategySarit Appel, Jeffry Goldstein, Marina Perelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancerEdith M Marom, Carlos H Martinez, Mylene T Truong, et al.
Open Forum Infectious Diseases|October 9, 2023
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Patients Treated With Anti-CD20 Monoclonal AntibodiesNadav Furie, Michal Mandelboim, Neta Zuckerman, et al.
Pageof 10